Skip to main content
AVAV
NASDAQ Manufacturing

AeroVironment Restates Q3 2026 Financials, Discloses Material Weakness in Internal Controls

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Aerospace & Defense Stocks · Industrial
Sentiment info
Negative
Importance info
9
Price
$164.03
Mkt Cap
$8.469B
52W Low
$156
52W High
$417.86
52W Position info
5.1% above low
Off High info
61% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

AVAV is trading near its 52-week low of $156 (5.1% above the low).

Summary

AeroVironment Inc. restated its Q3 2026 financials, revealing an $87.3 million understatement of net loss and a material weakness in internal controls, following a significant goodwill impairment.


Key Events · Corporate Governance and Compliance · AVAV

  • Financial Restatement

    Net loss for the nine months ended January 31, 2026, was understated by $87.272 million, and basic/diluted EPS was understated by $1.79. This restatement follows a prior 8-K announcement on 2026-06-22.

  • Material Weakness in Internal Controls

    The company identified a new material weakness in its internal control over financial reporting, specifically related to the preparation and review of goodwill impairment analysis, rendering disclosure controls ineffective.

  • Significant Goodwill Impairment

    The restatement includes a goodwill impairment charge of approximately $241 million in the Space reporting unit. This was triggered by a stop-work order on the BADGER phased array antenna systems program.


Analysis · AVAV · Manufacturing

AeroVironment Inc. filed an amended quarterly report (10-Q/A) to restate its financial statements for the three and nine months ended January 31, 2026. The restatement corrected an error that understated net loss by $87.272 million and basic/diluted EPS by $1.79 for the nine-month period. This error stemmed from a newly identified material weakness in internal control over financial reporting related to the goodwill impairment analysis for its Space reporting unit. The restatement also includes a significant goodwill impairment charge of approximately $241 million, triggered by a stop-work order on a key defense program. This indicates significant financial reporting issues and operational challenges in a key segment.

How filings like this one have moved

In the 30 days to Oct 27, 2026, 45.6% of the 241 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AVAV was trading at $164.03 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $8.5B. The 52-week trading range was $156.00 to $417.86. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AVAV - Latest Insights

AVAV
Sep 14, 2026, 1:13 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $154.78
Real-time Price: $124.50 info
Change: -$30.28 (-20%) info
Market Cap: $6.375B info
AVAV
Sep 11, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $147.74
Real-time Price: $124.50 info
Change: -$23.24 (-16%) info
Market Cap: $6.375B info
AVAV
Sep 10, 2026, 2:26 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $148.84
Real-time Price: $124.50 info
Change: -$24.34 (-16%) info
Market Cap: $6.375B info
AVAV
Sep 09, 2026, 6:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $150.41
Real-time Price: $124.50 info
Change: -$25.91 (-17%) info
Market Cap: $6.375B info
AVAV
Sep 09, 2026, 4:21 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $145.45
Real-time Price: $124.50 info
Change: -$20.95 (-14%) info
Market Cap: $6.375B info